间歇性肺部疾病中的肺高血压:超越支持性护理的管理选择
Kimberly D Fabyan1, Abhimanyu Chandel1, Christopher S King2
1Department of Pulmonary and Critical Care, Walter Reed National Military Medical Center, 8901, Rockville Pike, Bethesda, MD 20889 USA.
Current pulmonology reports
|June 26, 2023
概括
在间歇性肺病 (PH-ILD) 中的肺高血压管理正在发展. 吸入式特雷普罗斯尼尔现在已获得FDA批准,改善了患者的治疗结果,并指导了PH-ILD的新查建议.
科学领域:
- 肺部医学 肺部医学
- 心脏病学 心脏病学
- 间歇性肺病 间歇性肺病
背景情况:
- 由于间歇性肺病 (PH-ILD) 的肺高血压带来了复杂的管理挑战.
- 从历史上看,管理侧重于潜在的间歇性肺病 (ILD).
- 最近的治疗进展需要更新的临床指南.
研究的目的:
- 审查目前PH-ILD的诊断和管理策略.
- 突出最近临床试验发现对治疗范式的影响.
- 告知临床医生关于PH-ILD的不断发展的治疗选择.
主要方法:
- 审查关于PH-ILD诊断和管理的当前文献.
- 关键临床试验的分析,包括INCREASE试验.
- 综合证据支持新的治疗建议.
主要成果:
- 在INCREASE试验中,在PH-ILD.中证明了吸入式特雷普罗斯提尼尔的疗效.
- 吸入式特雷普罗斯尼尔是第一个FDA批准的PH-ILD治疗药物.
- 这项批准导致更新了对ILD患者PH查的建议.
结论:
- PH-ILD的管理正在转向疾病特异性疗法.
- 临床医生需要关于PH-ILD的查和治疗选择的最新知识.
- 目前正在进行的研究继续扩大PH-ILD的治疗可能性.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
221
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
221
Chronic Obstructive Pulmonary Disease-V: Management
2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.6K
Heart Failure VI: Adjunct Therapies
16
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
270
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
270
Pulmonary Hypertension: Classification and Pathogenesis
234
Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
There are various classifications for PH, each relating to different underlying causes and also...
234
Heart Failure V: Medical Management
15
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
15


